Influence of probucol on cholesterol and lipoprotein metabolism in man.
Open Access
- 1 August 1984
- journal article
- research article
- Published by Elsevier in Journal of Lipid Research
- Vol. 25 (8) , 780-790
- https://doi.org/10.1016/s0022-2275(20)37741-5
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Reduction of Serum Cholesterol in Heterozygous Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1983
- LOWERED HDL CHOLESTEROL AND INCIDENCE OF ISCHAEMIC HEART DISEASEThe Lancet, 1981
- Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1981
- Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug RegimenNew England Journal of Medicine, 1981
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980
- Drug management of hypercholesterolemiaAmerican Heart Journal, 1979
- Effect of probucol in hyperlipidemic patients during two years of administrationAmerican Heart Journal, 1978
- ProbucolDrugs, 1978
- Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia.Journal of Clinical Investigation, 1975
- The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observationsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972